Entresto 97 MG-103 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F3EN7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,549
Award facts
- Contract value 100% obligated
- $32,549.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units) valued at $32,549.15 on December 11, 2025, with completion anticipated by December 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to distribute a broad spectrum of pharmaceutical products and medical supplies to support military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its federal contract portfolio with the Defense Logistics Agency. The company's extensive experience delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains demonstrates its capability to meet federal requirements through open competition. This delivery order for Entresto, a cardiac care medication, exemplifies the company's role as a prime vendor supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F3EN7?
SPE2DR26F3EN7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F3EN7 worth?
The government has obligated $32,549 on SPE2DR26F3EN7.
Is contract SPE2DR26F3EN7 an order under another contract?
Yes. SPE2DR26F3EN7 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EN7 competed?
The extent of competition for SPE2DR26F3EN7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award